W.R. Berkley Corp’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

W.R. Berkley Corp’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-55,009	Closed	-$990K	–	182
2020 Q2	$990K	Buy	+55,009	New	+$765K	0.13%	73

W.R. Berkley Corp's PTLA Position: Q3 2020 in Review

W.R. Berkley Corp sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 55,009 shares — an estimated $990K sold.

W.R. Berkley Corp first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $990K in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

W.R. Berkley Corp reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
W.R. Berkley Corp sold 55,009 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $990K.
W.R. Berkley Corp first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
W.R. Berkley Corp's Portola Pharmaceuticals, Inc. position peaked at $990K in Q2 2020.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on W.R. Berkley Corp's 13F filing for Q3 2020, filed 16 Nov 2020.